ROCK inhibitors alter brain proteomic profiles and tau phosphorylation in iPSC‐derived human neurons and mouse model of Alzheimer’s disease
Roberto Collu, Elisa Giunti, Zheng Yin, Sarah Daley, Mei Chen, Qinqing Li, Peter J Morin, Richard Killick, Stephen T.C. Wong, Weiming Xia · 2025
Read ROCK inhibitors alter brain proteomic profiles and tau phosphorylation in iPSC‐derived human neurons and mouse model of Alzheimer’s disease by Roberto Collu, Elisa Giunti, Zheng Yin, Sarah Daley, Mei Chen, Qinqing Li, Peter J Morin, Richard Killick, Stephen T.C. Wong, Weiming Xia (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11709550.txt.
Description
Roberto Collu and a team of co-authors test whether blocking a family of enzymes can ease Alzheimer's disease changes. Their study appeared in twenty twenty-five. The enzymes, called ROCK, sit in pathways tied to the tau protein, which builds up in the sick brain.
The team used human neurons grown from stem cells and a mouse strain that carries a faulty tau gene. A drug called fasudil, and a close chemical relative, both lowered the altered tau levels in brain tissue. Treated neurons showed the same effect. Protein scans of mouse brains found shifts in energy-making and blood-brain barrier pathways after treatment. The authors say the results support developing ROCK blockers as Alzheimer's drugs.
Catalog record
| CREATOR | Roberto Collu, Elisa Giunti, Zheng Yin, Sarah Daley, Mei Chen, Qinqing Li, Peter J Morin, Richard Killick, Stephen T.C. Wong, Weiming Xia |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 1 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |